. AA activates Ca 2+ currents in VSMCs. Representative time courses (A) of whole-cell inward currents sampled at 100 mV showing that AA activates an inward Ca . 50 µM 2-APB, a CRAC channel blocker, did not block AA-activated currents (F). However, 2-APB at the same concentration abolished CRAC currents activated by store depletion through dialysis of 20 mM BAPTA through the patch pipette (D). Representative I-V curves are shown in B, E, and G, respectively. Statistical analysis on current densities of AA-activated currents and control (without AA) is shown in C. The sample size, mean/ range, and p-values for statistical comparisons for this figure and all subsequent supplemental figures are reported in Table S3 . Figure S2 . Orai2 knockdown has no effect on AA-activated currents in VSMCs and HEK293 cells. Quantitative RT-PCR shows Orai2 mRNA knockdown upon transfection of VSMCs with specific siRNA against Orai2 (A; no effect was observed on Orai1 or Orai3 expression). Statistical analyses on data are from three independent transfections, each performed in triplicates. (B-G) Orai2 knockdown (C, VSMCs; F, HEK293 cells) has no effect on AA-activated currents as compared with control siRNA (B, VSMCs; E, HEK293 cells). Representative Na Orai2 knockdown had no effect on CRAC current in both VSMCs and HEK293 cells. Whole-cell electrophysiological recording in VSMCs (A-D) or HEK293 cells (E-H) transfected with specific siRNA against Orai2 (siOrai2) or siControl, a nontargeting siRNA control. Respective time courses of whole-cell CRAC currents sampled at 100 mV show that Orai2 knockdown had no effect with Na Orai3 knockdown had no effect on CRAC current in both VSMCs and HEK293 cells. Whole-cell electrophysiological recordings in VSMCs infected with lentiviruses encoding shRNA against Orai3 (shOrai3) or shControl, a nontargeting control. Respective time courses of whole-cell inward currents sampled at 100 mV show that Orai3 knockdown had no effect with Na + /Ca 2+ CRAC currents (B) as compared with control (A). In HEK293 cells, Orai3 knockdown was achieved by transfection of siRNA targeting Orai3 (siOrai3). siOrai3 had no effect with Na 1) were lysed, and the whole-cell lysate was analyzed by Western blotting using anti-STIM1 antibody. Cells treated with DMSO or TG were processed to determine PM-resident STIM1 (PM-STIM1) 30 s after the addition of DMSO or TG. Cell surface proteins were biotinylated, extracted with streptavidin-coated agarose beads, and analyzed by SDS-PAGE and Western blotting using the anti-STIM1 antibody. Positions of molecular mass markers are shown on the right of the blots. Data summary is shown in C and is representative of eight (eYFP-STIM1) and six (untagged STIM1) independent experiments. Figure S13 . Calmodulin dialysis through the pipette and the addition of calmidazolium to the bath have no effect on AA-activated currents in HEK293 cells. Whole-cell patch-clamp electrophysiological recording on HEK293 cells. Dialyzing the cells with 10 µM calmodulin through patch pipette (B) or pretreatment of cells with 3 µM calmidazolium in the bath (C) has no effect on AA-activated currents as compared with control (A). Representative I-V curves are shown in D. Na + current densities measured under DVF bath solutions from three independent experiments are summarized in E. 
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